Maxima Mendez: Complete Results of the Pelacarsen Cardiovascular Outcomes Study at AHA 2026
Maxima Mendez, Chief Executive Officer at Cli-Lipid, shared a post on X about a recent article by Leslie Cho et al, published in The New England Journal of Medicine, adding:
“Pelacarsen and Cardiovascular Outcomes in Patients with High Lipoprotein(a), New England Journal of Medicine.
Complete Study Presented today at AHA 2026, Chicago, IL.”
Title: Pelacarsen and Cardiovascular Outcomes in Patients with High Lipoprotein(a)
Authors: Leslie Cho, Stephen J. Nicholls, Seth Frndak, Kathy Wolski, Børge G. Nordestgaard, Brian Manning, Eran Leitersdorf, Ulf Landmesser, Venu Menon, Jackie McCluskey, Michael J. Blaha, Ryuichi Morishita, A. Michael Lincoff, Ziqiang Zhao, Jing Wang, Raul D. Santos, Ioanna Gouni-Berthold, Sotirios Tsimikas, Anastasia Lesogor, Hui Cao, Steven E. Nissen
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 10, 2026, 16:28Can the VWF to ADAMTS-13 Ratio Predict Mortality in Sepsis-Induced Coagulopathy? – RPTH Journal
-
Nov 10, 2026, 16:28Ruth Willems: PhD Defence at Maastricht University on Thrombosis and Bleeding in HPB Disease
-
Nov 10, 2026, 16:09Edward Lee Carter: Factor XIa Inhibition Enters Clinical Practice
-
Nov 10, 2026, 16:08Edward C.C. Wong: Deriving Ferritin Cutoffs for Iron Deficiency Using RBC Parameters
-
Nov 10, 2026, 16:07Milad Abdalla: Decoding Hemoglobin Electrophoresis – A Practical Diagnostic Reference
-
Nov 10, 2026, 15:13Wolfgang Miesbach: Nonviral Gene Therapy for Haemophilia A Using Lipid Nanoparticles
-
Nov 10, 2026, 15:06Dahra Teles: First Speaking Experience at HEMO 2026 on First-Line Multiple Myeloma Treatment
-
Nov 10, 2026, 14:55Yazan Abou-Ismail: First FDA-Approved Factor XIa Inhibitor for Stroke Prevention
-
Nov 10, 2026, 14:49Ifeanyichukwu Ifechidere: The Role of Coagulation in Anaesthesia and Surgery